Tuning of major signaling networks (TGF-β, Wnt, Notch and Hedgehog) by miRNAs in human stem cells commitment to different lineages: Possible clinical application

Biomedicine and Pharmacotherapy

Volumn 91, Issue , 2017, Pages 849-860

  Aval, Sedigheh Fekri ^a,b   Lotfi, Hajie ^a   Sheervalilou, Roghayeh ^a   Zarghami, Nosratollah ^a,b,c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cancer stem cells (CSCs); Cardiovascular diseases (CVDs); MicroRNAs; Regeneration; Signaling pathway

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE SIALOPROTEIN; CYCLIN D1; MICRORNA; MICRORNA 1; MICRORNA 132; MICRORNA 133B; MICRORNA 141; MICRORNA 155; MICRORNA 20; MICRORNA 200; MICRORNA 21; MICRORNA 210; MICRORNA 34A; MICRORNA 34B; MICRORNA 34C; MICRORNA 375; MICRORNA 708; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; SMAD2 PROTEIN; SMAD3 PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UNINDEXED DRUG; UNTRANSLATED RNA; WNT PROTEIN;

3' UNTRANSLATED REGION; ACUTE LIVER FAILURE; ADIPOGENESIS; BONE DEVELOPMENT; CANCER STEM CELL; CELL INVASION; CELL LINEAGE; CELL MIGRATION; CELL SURVIVAL; CHRONIC LIVER DISEASE; CRIGLER NAJJAR SYNDROME TYPE I; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; FAMILIAL HYPERCHOLESTEROLEMIA; GENE OVEREXPRESSION; HEART INFARCTION; HEPATITIS C; HEREDITARY LIVER DISEASE; HISTONE MODIFICATION; HUMAN; HUMAN CELL; INDUCED PLURIPOTENT STEM CELL; LIVER CELL CARCINOMA; LIVER DISEASE; METASTASIS; NEURAL STEM CELL; OSTEOBLAST; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CELL; STEM CELL SELF-RENEWAL; STEM CELL TRANSPLANTATION; UREA CYCLE DISORDER; WNT SIGNALING PATHWAY; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; METABOLISM; STEM CELL;

ANIMALS; CELL LINEAGE; HUMANS; MICRORNAS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 85019102906     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.05.020     Document Type: Review

References (147)

1. Mathieu, J., Ruohola-Baker, H., Regulation of stem cell populations by microRNAs. Adv. Exp. Med. Biol. 786 (2013), 329–351.
2. Gangaraju, V.K., Lin, H., MicroRNAs: key regulators of stem cells. Nat. Rev. Mol. Cell Biol. 10 (2009), 116–125.
3. Huang, X.A., Lin, H., The microRNA regulation of stem cells. Wiley Interdiscip. Rev. Dev. Biol. 1 (2012), 83–95.
4. Yu, Z., Li, Y., Fan, H., Liu, Z., Pestell, R., miRNAs regulate stem cell self-renewal and differentiation. Front. Genet., 3, 2012.
5. Fekri Aval, S., Akbarzadeh, A., Yamchi, M.R., Zarghami, F., Nejati-Koshki, K., Zarghami, N., Gene silencing effect of SiRNA-magnetic modified with biodegradable copolymer nanoparticles on hTERT gene expression in lung cancer cell line. Artif. Cells Nanomed. Biotechnol. 44 (2016), 188–193.
6. Sheervalilou, R., Khamaneh, A.M., Sharifi, A., Nazemiyeh, M., Taghizadieh, A., Ansarin, K., et al. Using miR-10b: miR-1 and miR-30a expression profiles of bronchoalveolar lavage and sputum for early detection of non-small cell lung cancer. Biomed. Pharmacother. 88 (2017), 1173–1182.
7. Borggrefe, T., Lauth, M., Zwijsen, A., Huylebroeck, D., Oswald, F., Giaimo, B.D., The Notch intracellular domain integrates signals from Wnt, Hedgehog: TGFbeta/BMP and hypoxia pathways. Biochim. Biophys. Acta 1863 (2016), 303–313.
8. Heldin, C.H., Landstrom, M., Moustakas, A., Mechanism of TGF-beta signaling to growth arrest apoptosis, and epithelial-mesenchymal transition. Curr. Opin. Cell Biol. 21 (2009), 166–176.
9. Bartel, D.P., MicroRNAs: target recognition and regulatory functions. Cell 136 (2009), 215–233.
10. Yi, R., Fuchs, E., MicroRNAs and their roles in mammalian stem cells. J. Cell. Sci. 124 (2011), 1775–1783.
11. Srinageshwar, B., Maiti, P., Dunbar, G.L., Rossignol, J., Role of epigenetics in stem cell proliferation and differentiation: implications for treating neurodegenerative diseases. Int. J. Mol. Sci., 17, 2016.
12. Fagnocchi, L., Mazzoleni, S., Zippo, A., Integration of signaling pathways with the epigenetic machinery in the maintenance of stem cells. Stem Cells Int., 2016, 2016.
13. Cao, J., The functional role of long non-coding RNAs and epigenetics. Biol. Proced. Online, 16, 2014, 11.
14. Cui, X., He, H., He, F., Wang, S., Li, F., Bo, X., Network fingerprint: a knowledge-based characterization of biomedical networks. Sci. Rep., 5, 2015, 13286.
15. Staiger, H., Machicao, F., Fritsche, A., Haring, H.U., Pathomechanisms of type 2 diabetes genes. J. Clin. Endocrinol. Metab. 30 (2009), 557–585.
16. Matsubara, H., Ogawa, A., Treatment of idiopathic/hereditary pulmonary arterial hypertension. J. Am. Coll. Cardiol. 64 (2014), 243–249.
17. Rienhoff, H.Y. Jr., Yeo, C.Y., Morissette, R., Khrebtukova, I., Melnick, J., Luo, S., et al. A mutation in TGFB3 associated with a syndrome of low muscle mass, growth retardation, distal arthrogryposis and clinical features overlapping with Marfan and Loeys-Dietz syndrome. Am. J. Med. Genet. B Neuropsychiatr. Genet. 161a (2013), 2040–2046.
18. Doerdelmann, T., Kojetin, D.J., Baird-Titus, J.M., Solt, L.A., Burris, T.P., Rance, M., Structural and biophysical insights into the ligand-free Pitx2 homeodomain and a ring dermoid of the cornea inducing homeodomain mutant. Biochem. Mol. Biol. Educ. 51 (2012), 665–676.
19. Fares-Taie, L., Gerber, S., Chassaing, N., Clayton-Smith, J., Hanein, S., Silva, E., et al. ALDH1A3 mutations cause recessive anophthalmia and microphthalmia. Am. J. Hum. Genet. 92 (2013), 265–270.
20. O'Riordan, J.M., O'Donoghue, D., Green, A., Keegan, D., Hawkes, L.A., Payne, S.J., et al. Hereditary mixed polyposis syndrome due to a BMPR1A mutation. Colorectal Dis. 12 (2010), 570–573.
21. Brosens, L.A., Langeveld, D., van Hattem, W.A., Giardiello, F.M., Offerhaus, G.J., Juvenile polyposis syndrome. World J. Gastroenterol. 17 (2011), 4839–4844.
22. Ye, M., Berry-Wynne, K.M., Asai-Coakwell, M., Sundaresan, P., Footz, T., French, C.R., et al. Mutation of the bone morphogenetic protein GDF3 causes ocular and skeletal anomalies. Hum. Mol. Genet. 19 (2010), 287–298.
23. Waldron, J.M., McNamara, C., Hewson, A.R., McNamara, C.M., Axenfeld-Rieger syndrome (ARS): a review and case report. Spec. Care Dentist. 30 (2010), 218–222.
24. Kaplan, F.S., Le Merrer, M., Glaser, D.L., Pignolo, R.J., Goldsby, R.E., Kitterman, J.A., et al. Fibrodysplasia ossificans progressiva. Best Pract. Res. Clin. Rheumatol. 22 (2008), 191–205.
25. Mackenzie, I.R., Neumann, M., Bigio, E.H., Cairns, N.J., Alafuzoff, I., Kril, J., et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 119 (2010), 1–4.
26. Van Wesenbeeck, L., Cleiren, E., Gram, J., Beals, R.K., Benichou, O., Scopelliti, D., et al. Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am. J. Hum. Genet. 72 (2003), 763–771.
27. Clevers, H., Eyeing up new Wnt pathway players. Cell 139 (2009), 227–229.
28. Grover, M.P., Ballouz, S., Mohanasundaram, K.A., George, R.A., Goscinski, A., Crowley, T.M., et al. Novel therapeutics for coronary artery disease from genome-wide association study data. BMC Med. Genomics, 8(Suppl. 2), 2015, S1.
29. Skowron, P., Ramaswamy, V., Taylor, M.D., Genetic and molecular alterations across medulloblastoma subgroups. J. Mol Med. 93 (2015), 1075–1084.
30. Blaydon, D.C., Ishii, Y., O'Toole, E.A., Unsworth, H.C., Teh, M.T., Ruschendorf, F., et al. The gene encoding R-spondin 4 (RSPO4) a secreted protein implicated in Wnt signaling, is mutated in inherited anonychia. Nat. Genet. 38 (2006), 1245–1247.
31. Puri, P., Gosemann, J.H., Darlow, J., Barton, D.E., Genetics of vesicoureteral reflux. Nat. Rev. Urol. 8 (2011), 539–552.
32. Burgess, A.W., Faux, M.C., Layton, M.J., Ramsay, R.G., Wnt signaling and colon tumorigenesis?–a view from the periphery. Exp. Cell Res. 317 (2011), 2748–2758.
33. Maalouf, D., Megarbane, H., Chouery, E., Nasr, J., Badens, C., Lacoste, C., et al. A novel mutation in the PORCN gene underlying a case of almost unilateral focal dermal hypoplasia. Arch. Dermatol. 148 (2012), 85–88.
34. Lazar, A.J., Calonje, E., Grayson, W., Dei Tos, A.P., Mihm, M.C. Jr., Redston, M., et al. Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin. J. Cutan. Pathol. 32 (2005), 148–157.
35. Palmero, E.I., Achatz, M.I., Ashton-Prolla, P., Olivier, M., Hainaut, P., Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome. Curr. Opin. Oncol. 22 (2010), 64–69.
36. Marvin, M.L., Mazzoni, S.M., Herron, C.M., Edwards, S., Gruber, S.B., Petty, E.M., AXIN2-associated autosomal dominant ectodermal dysplasia and neoplastic syndrome. Am. J. Med. Genet. A 155a (2011), 898–902.
37. Neumann, M., Tolnay, M., Mackenzie, I.R., The molecular basis of frontotemporal dementia. Expert Rev. Mol. Med., 11, 2009, e23.
38. Sparrow, D.B., Sillence, D., Wouters, M.A., Turnpenny, P.D., Dunwoodie, S.L., Two novel missense mutations in HAIRY-AND-ENHANCER-OF-SPLIT-7 in a family with spondylocostal dysostosis. Eur. J. Hum. Genet. 18 (2010), 674–679.
39. Joutel, A., Pathogenesis of CADASIL: transgenic and knock-out mice to probe function and dysfunction of the mutated gene, Notch3 in the cerebrovasculature. Bioessays 33 (2011), 73–80.
40. Butz, H., Racz, K., Hunyady, L., Patocs, A., Crosstalk between TGF-beta signaling and the microRNA machinery. Trends Pharmacol. Sci. 33 (2012), 382–393.
41. Massague, J., TGFbeta signalling in context. Nat. Rev. Mol. Cell Biol. 13 (2012), 616–630.
42. Garcia, R., Nistal, J.F., Merino, D., Price, N.L., Fernandez-Hernando, C., Beaumont, J., et al. p-SMAD2/3 and DICER promote pre-miR-21 processing during pressure overload-associated myocardial remodeling. Biochim. Biophys. Acta 1852 (2015), 1520–1530.
43. Wu, M., Chen, G., Li, Y.P., TGF-beta and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone. Res., 4, 2016, 16009.
44. Rahman, M.S., Akhtar, N., Jamil, H.M., Banik, R.S., Asaduzzaman, S.M., TGF-beta/BMP signaling and other molecular events: regulation of osteoblastogenesis and bone formation. Bone. Res., 3, 2015, 15005.
45. Liu, H., Hao, W., Wang, X., Su H miR-23b targets Smad 3 and ameliorates the LPS-inhibited osteogenic differentiation in preosteoblast MC3T3-E1 cells. J. Toxicol. Sci. 41 (2016), 185–193.
46. Guo, C., Yuan, L., Wang, J.G., Wang, F., Yang, X.K., Zhang, F.H., et al. Lipopolysaccharide (LPS) induces the apoptosis and inhibits osteoblast differentiation through JNK pathway in MC3T3-E1 cells. Inflammation 37 (2014), 621–631.
47. Wang, P., Wang, Y., Tang, W., Wang, X., Pang, Y., Yang, S., et al. Bone morphogenetic protein-9 enhances osteogenic differentiation of human periodontal ligament stem cells via the JNK pathway. PLoS One, 12, 2017.
48. Eskildsen, T., Taipaleenmaki, H., Stenvang, J., Abdallah, B.M., Ditzel, N., Nossent, A.Y., et al. MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 6139–6144.
49. Hao, C., Yang, S., Xu, W., Shen, J.K., Ye, S., Liu, X., et al. MiR-708 promotes steroid-induced osteonecrosis of femoral head, suppresses osteogenic differentiation by targeting SMAD3. Sci. Rep., 6, 2016, 22599.
50. Lagna, G., Ku, M.M., Nguyen, P.H., Neuman, N.A., Davis, B.N., Hata, A., Control of phenotypic plasticity of smooth muscle cells by bone morphogenetic protein signaling through the myocardin-related transcription factors. J. Biol. Chem. 282 (2007), 37244–37255.
51. Davis, B.N., Hilyard, A.C., Lagna, G., Hata, A., SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454 (2008), 56–61.
52. Davis, B.N., Hilyard, A.C., Nguyen, P.H., Lagna, G., Hata, A., Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol. Cell 39 (2010), 373–384.
53. Jiang, Y., Yin, H., Zheng, X.L., MicroRNA-1 inhibits myocardin-induced contractility of human vascular smooth muscle cells. J. Cell. Physiol. 225 (2010), 506–511.
54. Wang, N., Ren, G.D., Zhou, Z., Xu, Y., Qin, T., Yu, R.F., et al. Cooperation of myocardin and Smad2 in inducing differentiation of mesenchymal stem cells into smooth muscle cells. IUBMB Life 64 (2012), 331–339.
55. Karakikes, I., Chaanine, A.H., Kang, S., Mukete, B.N., Jeong, D., Zhang, S., et al. Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling. J. Am. Heart Assoc., 2, 2013, e000078.
56. Song, J.L., Nigam, P., Tektas, S.S., Selva E microRNA regulation of Wnt signaling pathways in development and disease. Cell. Signal. 27 (2015), 1380–1391.
57. Inui, M., Martello, G., Piccolo, S., MicroRNA control of signal transduction. Nat. Rev. Mol. Cell Biol. 11 (2010), 252–263.
58. Komiya, Y., Habas, R., Wnt signal transduction pathways. Organogenesis 4 (2008), 68–75.
59. Tamai, K., Semenov, M., Kato, Y., Spokony, R., Liu, C., Katsuyama, Y., et al. LDL-receptor-related proteins in Wnt signal transduction. Nature 407 (2000), 530–535.
60. González-Sancho, J.M., Brennan, K.R., Castelo-Soccio, L.A., Brown, A.M.C., Wnt proteins induce dishevelled phosphorylation via an LRP5/6- independent mechanism: irrespective of their ability to stabilize β-catenin. Mol. Cell. Biol. 24 (2004), 4757–4768.
61. Eastman, Q., Grosschedl, R., Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr. Opin. Cell Biol. 11 (1999), 233–240.
62. MacDonald, B.T., Tamai, K., He, X., Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev. Cell 17 (2009), 9–26.
63. He, X., Semenov, M., Tamai, K., Zeng, X., LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 131 (2004), 1663–1677.
64. Shimizu, H., Julius, M.A., Giarre, M., Zheng, Z., Brown, A.M., Kitajewski, J., Transformation by Wnt family proteins correlates with regulation of beta-catenin. Cell Growth Differ. 8 (1997), 1349–1358.
65. Rubinfeld, B., Souza, B., Albert, I., Muller, O., Chamberlain, S.H., Masiarz, F.R., et al. Association of the APC gene product with beta-catenin. Science 262 (1993), 1731–1734.
66. Pulikkan, J.A., Peramangalam, P.S., Dengler, V., Ho, P.A., Preudhomme, C., Meshinchi, S., et al. C/EBPalpha regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations. Blood 116 (2010), 5638–5649.
67. Hermeking, H., The miR-34 family in cancer and apoptosis. Cell Death Differ. 17 (2010), 193–199.
68. Chen, L., Holmstrom, K., Qiu, W., Ditzel, N., Shi, K., Hokland, L., et al. MicroRNA-34a inhibits osteoblast differentiation and in vivo bone formation of human stromal stem cells. Stem Cells 32 (2014), 902–912.
69. Chen, Q., Liu, W., Sinha, K.M., Yasuda, H., de Crombrugghe, B., Identification and characterization of microRNAs controlled by the osteoblast-specific transcription factor Osterix. PLoS One, 8, 2013, e58104.
70. Fedarko, N.S., Jain, A., Karadag, A., Van Eman MR Fisher LW. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin. Cancer Res. 7 (2001), 4060–4066.
71. Hassan, M.Q., Maeda, Y., Taipaleenmaki, H., Zhang, W., Jafferji, M., Gordon, J.A.R., et al. MiR-218 directs a wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells. J. Biol. Chem. 287 (2012), 42084–42092.
72. Zhang, W.B., Zhong, W.J., Wang, L., A signal-amplification circuit between miR-218 and Wnt/beta-catenin signal promotes human adipose tissue-derived stem cells osteogenic differentiation. Bone 58 (2014), 59–66.
73. Yang, F., Yang, D., Tu, J., Zheng, Q., Cai, L., Wang, L., Strontium enhances osteogenic differentiation of mesenchymal stem cells and in vivo bone formation by activating Wnt/catenin signaling. Stem Cells 29 (2011), 981–991.
74. Kapinas, K., Kessler, C., Ricks, T., Gronowicz, G., Delany AM miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. J. Biol. Chem. 285 (2010), 25221–25231.
75. Lu, T.Y., Lin, B., Li, Y., Arora, A., Han, L., Cui, C., et al. Overexpression of microRNA-1 promotes cardiomyocyte commitment from human cardiovascular progenitors via suppressing WNT and FGF signaling pathways. J. Mol. Cell. Cardiol. 63 (2013), 146–154.
76. Shen, X., Soibam, B., Benham, A., Xu, X., Chopra, M., Peng, X., et al. miR-322/-503 cluster is expressed in the earliest cardiac progenitor cells and drives cardiomyocyte specification. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 9551–9556.
77. Zhang, L.L., Liu, J.J., Liu, F., Liu, W.H., Wang, Y.S., Zhu, B., et al. MiR-499 induces cardiac differentiation of rat mesenchymal stem cells through wnt/beta-catenin signaling pathway. Biochem. Biophys. Res. Commun. 420 (2012), 875–881.
78. Wang, Y., Liu, J., Cui, J., Sun, M., Du, W., Chen, T., et al. MiR218 modulates wnt signaling in mouse cardiac stem cells by promoting proliferation and inhibiting differentiation through a positive feedback loop. Sci. Rep., 6, 2016.
79. Fox, K.E., Fankell, D.M., Erickson, P.F., Majka, S.M., Crossno, J.T. Jr., Klemm, D.J., Depletion of cAMP-response element-binding protein/ATF1 inhibits adipogenic conversion of 3T3-L1 cells ectopically expressing CCAAT/enhancer-binding protein (C/EBP) alpha C/EBP beta, or PPAR gamma 2. J. Biol. Chem. 281 (2006), 40341–40353.
80. Shi, C., Zhang, M., Tong, M., Yang, L., Pang, L., Chen, L., et al. MiR-148a is associated with obesity and modulates adipocyte differentiation of mesenchymal stem cells through wnt signaling. Sci. Rep., 5, 2015, 9930.
81. Huang, S., Wang, S., Bian, C., Yang, Z., Zhou, H., Zeng, Y., et al. Upregulation of miR-22 promotes osteogenic differentiation and inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by repressing HDAC6 protein expression. Stem Cells Dev. 21 (2012), 2531–2540.
82. Yang, Z., Bian, C., Zhou, H., Huang, S., Wang, S., Liao, L., et al. MicroRNA hsa-miR-138 inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells through adenovirus EID-1. Stem Cells Dev. 20 (2011), 259–267.
83. Chen, C., Xiang, H., Peng, Y.L., Peng, J., Jiang, S.W., Mature miR-183 negatively regulated by transcription factor GATA3, promotes 3T3-L1 adipogenesis through inhibition of the canonical Wnt/beta-catenin signaling pathway by targeting LRP6. Cell. Signal. 26 (2014), 1155–1165.
84. Cui, Y., Han, J., Xiao, Z., Chen, T., Wang, B., Chen, B., et al. The miR-20-Rest-Wnt signaling axis regulates neural progenitor cell differentiation. Sci. Rep., 6, 2016, 23300.
85. Stappert, L., Roese-Koerner, B., Brüstle, O., The role of microRNAs in human neural stem cells: neuronal differentiation and subtype specification. Cell Tissue Res. 359 (2015), 47–64.
86. Shin, K., Lee, J., Guo, N., Kim, J., Lim, A., Qu, L., et al. Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder. Nature 472 (2011), 110–114.
87. Beachy, P.A., Hymowitz, S.G., Lazarus, R.A., Leahy, D.J., Siebold, C., Interactions between Hedgehog proteins and their binding partners come into view. Genes Dev. 24 (2010), 2001–2012.
88. Hui, C.C., Angers, S., Gli proteins in development and disease. Annu. Rev. Cell Dev. Biol. 27 (2011), 513–537.
89. Hooper, J.E., Scott, M.P., Communicating with Hedgehogs. Nat. Rev. Mol. Cell Biol. 6 (2005), 306–317.
90. Beachy, P.A., Karhadkar, S.S., Berman, D.M., Tissue repair and stem cell renewal in carcinogenesis. Nature 432 (2004), 324–331.
91. Ng, J.M., Curran, T., The Hedgehog's tale: developing strategies for targeting cancer. Nat. Rev. Cancer 11 (2011), 493–501.
92. Hyun, J., Wang, S., Kim, J., Kim, G.J., Jung, Y., MicroRNA125b-mediated Hedgehog signaling influences liver regeneration by chorionic plate-derived mesenchymal stem cells. Sci. Rep., 5, 2015, 14135.
93. Çiçek, I., Karaca, S., Brankatschk, M., Eaton, S., Urlaub, H., Shcherbata, H.R., Hedgehog signaling strength is orchestrated by the mir-310 cluster of MicroRNAs in response to diet. Genetics 202 (2016), 1167–1183.
94. Yekta, S., Tabin, C.J., Bartel, D.P., MicroRNAs in the Hox network: an apparent link to posterior prevalence. Nat. Rev. Genet. 9 (2008), 789–796.
95. Karastergiou, K., Fried, S.K., Xie, H., Lee, M.J., Divoux, A., Rosencrantz, M.A., et al. Distinct developmental signatures of human abdominal and gluteal subcutaneous adipose tissue depots. J. Clin. Endocrinol. Metab. 98 (2013), 362–371.
96. Hoss, A.G., Kartha, V.K., Dong, X., Latourelle, J.C., Dumitriu, A., Hadzi, T.C., et al. MicroRNAs located in the hox gene clusters are implicated in Huntington's disease pathogenesis. PLoS Genet., 10, 2014, e1004188.
97. Naguibneva, I., Ameyar-Zazoua, M., Polesskaya, A., Ait-Si-Ali, S., Groisman, R., Souidi, M., et al. The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat. Cell Biol. 8 (2006), 278–284.
98. Larsen, B.M., Marty-Santos, L., Newman, M., Lukacs, D.T., Spence, J.R., Wellik, D.M., Hox6 genes modulate in vitro differentiation of mESCs to insulin-producing cells. In Vitro Cell. Dev. Biol. Anim.5 52 (2016), 974–982.
99. Fortini, M.E., Notch signaling: the core pathway and its posttranslational regulation. Dev. Cell 16 (2009), 633–647.
100. D'Souza, B., Meloty-Kapella, L., Weinmaster, G., Canonical and non-canonical Notch ligands. Curr. Top. Dev. Biol. 92 (2010), 73–129.
101. Andersson, E.R., Sandberg, R., Lendahl, U., Notch signaling: simplicity in design versatility in function. Development 138 (2011), 3593–3612.
102. Bae, Y., Yang, T., Zeng, H.-C., Campeau, P.M., Chen, Y., Bertin, T., et al. miRNA-34c regulates Notch signaling during bone development. Hum. Mol. Genet. 21 (2012), 2991–3000.
103. Sun, F., Wan, M., Xu, X., Gao, B., Zhou, Y., Sun, J., et al. Crosstalk between miR-34a and notch signaling promotes differentiation in apical papilla stem cells (SCAPs). J. Dent. Res. 93 (2014), 589–595.
104. Cai, Z., Zhao, B., Deng, Y., Shangguan, S., Zhou, F., Zhou, W., et al. Notch signaling in cerebrovascular diseases (Review). Mol. Med. Rep. 14 (2016), 2883–2898.
105. Wang, L., Zhang, H., Rodriguez, S., Cao, L., Parish, J., Mumaw, C., et al. Notch-dependent repression of miR-155 in the bone marrow niche regulates hematopoiesis in an NF-kappaB-dependent manner. Cell Stem Cell 15 (2014), 51–65.
106. Ben-Shushan, E., Feldman, E., Reubinoff, B.E., Notch signaling regulates motor neuron differentiation of human embryonic stem cells. Stem Cells 33 (2015), 403–415.
107. de la Pompa, J.L., Notch signaling in cardiac development and disease. Pediatr. Cardiol. 30 (2009), 643–650.
108. Wang, L., Song, G., Liu, M., Chen, B., Chen, Y., Shen, Y., et al. MicroRNA-375 overexpression influences P19 cell proliferation: apoptosis and differentiation through the Notch signaling pathway. Int. J. Mol. Med. 37 (2016), 47–55.
109. Brabletz, S., Bajdak, K., Meidhof, S., Burk, U., Niedermann, G., Firat, E., et al. The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. EMBO J. 30 (2011), 770–782.
110. Sheervalilou, R., Ansarin, K., Fekri Aval, S., Shirvaliloo, S., Pilehvar-Soltanahmadi, Y., Mohammadian, M., et al. An update on sputum MicroRNAs in lung cancer diagnosis. Diagn. Cytopathol. 44 (2016), 442–449.
111. Lou, Y.-L., Guo, F., Liu, F., Gao, F.-L., Zhang, P.-Q., Niu, X., et al. miR-210 activates notch signaling pathway in angiogenesis induced by cerebral ischemia. Mol. Cell. Biochem. 370 (2012), 45–51.
112. Majidinia, M., Alizadeh, E., Yousefi, B., Akbarzadeh, M., Zarghami, N., Downregulation of notch signaling pathway as an effective chemosensitizer for cancer treatment. Drug Res. (Stuttg) 66 (2016), 571–579.
113. Reya, T., Morrison, S.J., Clarke, M.F., Weissman, I.L., Stem cells cancer, and cancer stem cells. Nature 414 (2001), 105–111.
114. Li, L., Borodyansky, L., Yang, Y., Genomic instability en route to and from cancer stem cells. ABBV Cell Cycle 8 (2009), 1000–1002.
115. Guo, L., Zhang, Y., Zhang, L., Huang, F., Li, J., MicroRNAs, Wang S., TGF-β signaling, and the inflammatory microenvironment in cancer. Tumour Biol. 37 (2016), 115–125.
116. Drabsch, Y., ten Dijke, P., TGF-beta signalling and its role in cancer progression and metastasis. Cancer Metastasis Rev. 31 (2012), 553–568.
117. Peng, Y., Croce, C.M., The role of MicroRNAs in human cancer. Signal Transduct. Target. Ther., 1, 2016, 15004.
118. Kong, W., Yang, H., He, L., Zhao, J.J., Coppola, D., Dalton, W.S., et al. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol. Cell. Biol. 28 (2008), 6773–6784.
119. Mestdagh, P., Boström, A.-K., Impens, F., Fredlund, E., Van Peer, G., De Antonellis, P., et al. The miR-17-92 microRNA cluster regulates multiple components of the TGF-β pathway in neuroblastoma. Mol. Cell 40 (2010), 762–773.
120. He, L., Thomson, J.M., Hemann, M.T., Hernando-Monge, E., Mu, D., Goodson, S., et al. A microRNA polycistron as a potential human oncogene. Nature 435 (2005), 828–833.
121. Castellano, L., Giamas, G., Jacob, J., Coombes, R.C., Lucchesi, W., Thiruchelvam, P., et al. The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 15732–15737.
122. Lanza, G., Ferracin, M., Gafà, R., Veronese, A., Spizzo, R., Pichiorri, F., et al. mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol. Cancer, 6, 2007, 54.
123. Petrocca, F., Visone, R., Onelli, M.R., Shah, M.H., Nicoloso, M.S., de Martino, I., et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13 (2008), 272–286.
124. Borah, A., Raveendran, S., Rochani, A., Maekawa, T., Kumar, D.S., Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy. Oncogenesis, 4, 2015, e177-.
125. Jamieson, C.H.M., Ailles, L.E., Dylla, S.J., Muijtjens, M., Jones, C., Zehnder, J.L., et al. Granulocyte–macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. New Engl. J. Med. 351 (2004), 657–667.
126. Nagel, R., le Sage, C., Diosdado, B., van der Waal, M., Oude Vrielink, J.A., Bolijn, A., et al. Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res. 68 (2008), 5795–5802.
127. Isobe, T., Hisamori, S., Hogan, D.J., Zabala, M., Hendrickson, D.G., Dalerba, P., et al. miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway. Elife, 3, 2014.
128. Chung, T.K., Lau, T.S., Cheung, T.H., Yim, S.F., Lo, K.W., Siu, N.S., et al. Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1. Int. J. Cancer 130 (2012), 1036–1045.
129. White, N., Khella, H., Grigull, J., Adzovic, S., Youssef, Y., Honey, R., et al. miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215. Br. J. Cancer 105 (2011), 1741–1749.
130. Shankaran, H., Resat, H., Wiley, H.S., Cell surface receptors for signal transduction and ligand transport: a design principles study. PLoS Comput. Biol., 3, 2007, e101.
131. Wang, R.N., Green, J., Wang, Z., Deng, Y., Qiao, M., Peabody, M., et al. Bone Morphogenetic Protein (BMP) signaling in development and human diseases. Genes Dis. 1 (2014), 87–105.
132. Nejati-Koshki, K., Mortazavi, Y., Pilehvar-Soltanahmadi, Y., Sheoran, S., Zarghami, N., An update on application of nanotechnology and stem cells in spinal cord injury regeneration. Biomed. Pharmacother. 90 (2017), 85–92.
133. O'Brien, T., Barry, F.P., Stem cell therapy and regenerative medicine. Mayo Clin. Proc. 84 (2009), 859–861.
134. Gersh, B.J., Simari, R.D., Behfar, A., Terzic, C.M., Terzic, A., Cardiac cell repair therapy: a clinical perspective. Mayo Clin. Proc. 84 (2009), 876–892.
135. Vosough, M., Moslem, M., Pournasr, B., Baharvand, H., Cell-based therapeutics for liver disorders. Br. Med. Bull. 100 (2011), 157–172.
136. Hyun, J., Wang, S., Kim, J., Kim, G.J., Jung, Y., MicroRNA125b-mediated Hedgehog signaling influences liver regeneration by chorionic plate-derived mesenchymal stem cells. Sci. Rep., 5, 2015, 14135.
137. Zhang, Z., Lin, H., Shi, M., Xu, R., Fu, J., Lv, J., et al. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J. Gastroenterol. Hepatol. 27:Suppl. 2 (2012), 112–120.
138. Saito, T., Okumoto, K., Haga, H., Nishise, Y., Ishii, R., Sato, C., et al. Potential therapeutic application of intravenous autologous bone marrow infusion in patients with alcoholic liver cirrhosis. Stem Cells Dev. 20 (2011), 1503–1510.
139. Garg, V., Garg, H., Khan, A., Trehanpati, N., Kumar, A., Sharma, B.C., et al. Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology 142 (2012), 505–512 e1.
140. Dhawan, A., Mitry, R.R., Hughes, R.D., Hepatocyte transplantation for liver-based metabolic disorders. J. Inherit. Metab. Dis. 29 (2006), 431–435.
141. Alizadeh, E., Akbarzadeh, A., Eslaminejad, M.B., Barzegar, A., Hashemzadeh, S., Nejati-Koshki, K., et al. Up regulation of liver-enriched transcription factors HNF4a and HNF6 and liver-specific microRNA (miR-122) by inhibition of let-7b in mesenchymal stem cells. Chem. Biol. Drug Des. 85 (2015), 268–279.
142. Liu, Y., Liu, D.-L., Dong, L.-L., Wen, D., Shi, D.-M., Zhou, J., et al. miR-612 suppresses stem cell-like property of hepatocellular carcinoma cells by modulating Sp1/Nanog signaling. Cell. Death. Dis., 7, 2016, e2377.
143. Zhang, Y., Wei, W., Cheng, N., Wang, K., Li, B., Jiang, X., et al. Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Hepatology 56 (2012), 1631–1640.
144. Nagaya, N., Kangawa, K., Itoh, T., Iwase, T., Murakami, S., Miyahara, Y., et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112 (2005), 1128–1135.
145. Mu, D., Zhang, X.-L., Xie, J., Yuan, H.-H., Wang, K., Huang, W., et al. Intracoronary transplantation of mesenchymal stem cells with overexpressed integrin-linked kinase improves cardiac function in porcine myocardial infarction. Sci. Rep., 6, 2016, 19155.
146. Rao, P.K., Kumar, R.M., Farkhondeh, M., Baskerville, S., Lodish, H.F., Myogenic factors that regulate expression of muscle-specific microRNAs. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 8721–8726.
147. Dakhlallah, D., Zhang, J., Yu, L., Marsh, C.B., Angelos, M.G., Khan, M., MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart. J. Cardiovasc. Pharmacol. 65 (2015), 241–251.